United States · FDA National Drug Code directory
BRAFTOVI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70255-025_7dd6ed01-4c55-49ef-b55d-6d82c5dfc02e
- Product NDC
- 70255-025
- Form
- CAPSULE
- Composition / generic term
- Encorafenib
- Labeler
- Array BioPharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180627
- Source listing expiry
- 20271231
Source-listed ingredients
- ENCORAFENIB — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BOTTLE in 1 CARTON (70255-025-01) / 90 CAPSULE in 1 BOTTLE (70255-025-02) · 70255-025-01
- 2 BOTTLE in 1 CARTON (70255-025-03) / 60 CAPSULE in 1 BOTTLE (70255-025-04) · 70255-025-03
- 90 CAPSULE in 1 BOTTLE (70255-025-05) · 70255-025-05
- 60 CAPSULE in 1 BOTTLE (70255-025-06) · 70255-025-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →